Patents by Inventor John E. Mott

John E. Mott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial methods and materials
    Publication number: 20030180821
    Abstract: The present invention provides methods of identifying agents that bind gene products critical for the survival of microbes, preferably Staphylococcus microbes, including agents that interfere with the expression of such gene products and agents that interfere with the function of such gene products.
    Type: Application
    Filed: May 2, 2003
    Publication date: September 25, 2003
    Applicant: PHARMACIA & UPJOHN COMPANY
    Inventors: Che-Shen C. Tomich, Cheryl L. Quinn, Staffan Arvidson, John E. Mott, Douglas W. Harris
  • Antimicrobial methods and materials
    Publication number: 20030087321
    Abstract: The present invention provides methods of identifying agents that bind gene products critical for the survival of microbes, preferably Staphylococcus microbes, including agents that interfere with the expression of such gene products and agents that interfere with the function of such gene products.
    Type: Application
    Filed: September 28, 2001
    Publication date: May 8, 2003
    Inventors: Che-Shen C. Tomich, Cheryl L. Quinn, Staffan Arvidson, John E. Mott, Douglas W. Harris
  • Somatotropin analogs
    Patent number: 5631227
    Abstract: The present invention provides analogs of somatotropins wherein the asparagine residue corresponding to position 99 of a bovine somatotropin is replaced with a compound selected from the group consisting of proline, aspartic acid, glutamic acid, serine, glycine, serine-serine or serine-aspartic acid. Particularly preferred analogs are bovine somatotropin and their use to increase milk production.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: May 20, 1997
    Assignee: The Upjohn Company
    Inventors: Gary C. Harbour, John G. Hoogerheide, Robert L. Garlick, Stephen B. Lyle, John E. Mott
  • Eliminating internal initiation of soluble CD4 gene
    Patent number: 5510256
    Abstract: The present invention is based upon the discovery that proteins made from genes that include the CD4 sequence in its cDNA can make additional polypeptides as a result of internal translation initiation. This invention is thus directed to DNA sequences which eliminate internal initiation expression in sCD4.
    Type: Grant
    Filed: December 29, 1994
    Date of Patent: April 23, 1996
    Assignee: The Upjohn Company
    Inventors: Richard J. Kirschner, John E. Mott, Frances M. Eckenrode, David P. Brunner
  • CDNAS encoding somatotropin, expression vectors and hosts
    Patent number: 5240837
    Abstract: This invention discloses novel species of cDNAs encoding somatotropins, novel dual replicon vectors, hosts for such vectors and hosts for expressing the somatotropins encoded by such cDNAs.
    Type: Grant
    Filed: August 18, 1989
    Date of Patent: August 31, 1993
    Assignee: The Upjohn Company
    Inventors: Che-Shen C. Tomich, Eric R. Olson, John E. Mott